Table 3.
Relapse-free survival, % | pa | |
---|---|---|
Her-2 status | 0.003 | |
|
71 | |
|
27 | |
Initial nodal status | 0.01 | |
|
74 | |
|
36 | |
Radiotherapy of metastatic lesions | 0.01 | |
|
63 | |
|
18 | |
Hormone receptor status | 0.02 | |
|
62 | |
|
33 | |
Category of primary tumor | 0.02 | |
|
73 | |
|
52 | |
|
64 | |
|
0 | |
Number of metastatic lesions | 0.03 | |
|
63 | |
|
29 | |
Site of metastatic lesions | 0.11 | |
|
67 | |
|
59 | |
|
27 | |
Surgery of metastatic lesions | 0.73 | |
|
56 | |
|
52 |
Univariate analysis.